Company / Inventory
CUMBERLAND PHARMACEUTICALS INC Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$6.2M
FY2025
5-year range
$4.0M / $9.9M
FY2021-FY2025
Trend
+55.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory returned to growth in FY2025 after 2 years of decline, reaching $6M.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of -10.2%.
Improved from $5M to $6M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -14.2%
- 5-Year CAGR
- -10.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.2%, indicating a declining trend.
- In FY2025, inventory increased 55.6% year-over-year.
- Peak inventory was recorded in FY2018.
- Lowest inventory in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.2M | +55.6% |
| FY2024 | $4.0M | -13.2% |
| FY2023 | $4.6M | -53.3% |
| FY2022 | $9.9M | +17.0% |
| FY2021 | $8.4M | -20.8% |
| FY2020 | $10.6M | +19.9% |
| FY2019 | $8.9M | -26.6% |
| FY2018 | $12.1M | +79.3% |
| FY2017 | $6.7M | +25.4% |
| FY2016 | $5.4M | +25.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026